Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Leuk Lymphoma ; 54(12): 2720-7, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23547841

ABSTRACT

Myelodysplastic syndromes (MDS) are a group of hematopoietic malignancies characterized by ineffective hematopoiesis. Recently, we identified MDS-associated microRNAs (miRNAs) that are down-regulated in MDS. This study examines possible explanations for that observed down-regulation of miRNA expression in MDS. Since genomic losses are insufficient to explain the down-regulation of all our MDS-associated miRNAs, we explored other avenues. We demonstrate that these miRNAs are predominantly intragenic, and that, in many cases, they and their host genes are expressed in a similar pattern during myeloid maturation, suggesting their co-regulation. This co-regulation is further supported by the down-regulation of several of the host genes in MDS and increased methylation of the shared promoters of several miRNAs and their respective host genes. These studies identify a role of hypermethylation of miRNA promoters in the down-regulation of MDS-associated miRNAs, unifying research on miRNAs in MDS and epigenetic regulation in MDS into a common pathway.


Subject(s)
DNA Methylation , Gene Expression Regulation , MicroRNAs/genetics , Myelodysplastic Syndromes/genetics , Promoter Regions, Genetic , Cell Differentiation/drug effects , Cell Line, Tumor , Chromosome Deletion , Chromosome Mapping , CpG Islands , Gene Expression Regulation/drug effects , Humans , MicroRNAs/metabolism , Transcriptome , Tretinoin/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...